 adopt immunotherapi human pancreat cancer lymphokine-activ killer cell nude mous model pancreat cancer cell line orthotop heterotop posit young swiss/nih nude mice adopt immunotherapi mice human cancer cell subcutan tissu duoden lobe pancrea mice group group IA lak human lymphokine-activ killer lak cell normal donor tail vein inject unit human recombin hour day group IB dose group IC placebo consist ml hour group ID lak lak cell toxic group IB mortal rate anim mortal group IA none group IA IB anim pancreat cancer experi anim day group IC group ID area growth curv subcutan tumor cours treatment pancreat tumor weight end treatment group subcutan tumor reduc rate growth group IA anim treatment pancreat tumor growth group IA anim group IB slow tumor growth intermedi group IA group IC group ID similar experi irradi rad mice nine nude mice tumor lak group iia group iib placebo group iic antitumor effect present irradi mice signific differ group iia group differ histolog characterist tumor control mice mice inhibit tumor growth human lak cell result adopt immunotherapi human lak cell human recombin effect human pancreat cancer nude mice effect independ antitumor activ administr